Asia: Guardant Health buys out partners in AMEA JV

Nasdaq-listed Guardant Health, a precision oncology company, has purchased the remaining shares of Guardant Health AMEA held by SoftBank and its affiliates for approximately US$177.8m, giving the company full control over operations throughout the Asia, Middle East and Africa region. In May 2018, Guardant Health and SoftBank Vision Fund established the Guardant Health AMEA joint…